IMPURITIES AVAILABLE FOR 'Teneligliptin Hydrobromide'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Teneligliptin Hydrobromide. Teneligliptin hydrobromide is a dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. By inhibiting DPP-4, it increases levels of incretin hormones such as GLP-1 and GIP, enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner. The drug features a unique “J-shaped” anchor-lock structure that provides strong, selective DPP-4 binding and prolonged action. It offers effective HbA1c reduction both as monotherapy and in combination with other antidiabetic agents. Teneligliptin is primarily metabolized by CYP3A4 and FMO3, allowing flexible use in patients with renal impairment. It is generally well tolerated, with mild adverse effects such as headache, nasopharyngitis, and gastrointestinal discomfort. The medication has minimal risk of hypoglycemia when used without insulin or sulfonylureas. Its once-daily dosing improves patient adherence. Buy high quality Teneligliptin Hydrobromide from Omsynth Lifesciences.